Enabling oral delivery of thuricin CD, a two-component peptide antimicrobial, using chitosan-coated liposomes.
RSC Pharmaceutics · 2026
DOI: 10.1039/d6pm00261g ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Camila Viera Herrera und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Gastrointestinal infections are becoming increasingly difficult to treat using standard therapies due to antimicrobial resistance, a significant threat to global health. Thuricin CD, a narrow spectrum bacteriocin, has shown strong...
Zitieren
APA
Herrera, C. V., O'Connor, P. M., Ross, R. P., Hill, C., & Hudson, S. (2026). Enabling oral delivery of thuricin CD, a two-component peptide antimicrobial, using chitosan-coated liposomes. RSC Pharmaceutics. https://doi.org/10.1039/d6pm00261g
Vancouver
Herrera CV, O'Connor PM, Ross RP, Hill C, Hudson S. Enabling oral delivery of thuricin CD, a two-component peptide antimicrobial, using chitosan-coated liposomes. RSC Pharmaceutics. 2026. doi:10.1039/d6pm00261g
BibTeX
@article{Herrera2026,
author = {Herrera, Camila Viera and O'Connor, Paula M. and Ross, R. Paul and Hill, Colin and Hudson, Sarah},
title = {Enabling oral delivery of thuricin CD, a two-component peptide antimicrobial, using chitosan-coated liposomes},
journal = {RSC Pharmaceutics},
year = {2026},
doi = {10.1039/d6pm00261g}
}
EUVIMED